NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 20 04:00PM ET
21.00
Dollar change
-0.46
Percentage change
-2.14
%
IndexRUT P/E- EPS (ttm)-1.00 Insider Own1.23% Shs Outstand62.77M Perf Week-1.87%
Market Cap1.32B Forward P/E7.83 EPS next Y2.68 Insider Trans-67.70% Shs Float62.00M Perf Month11.82%
Enterprise Value1.32B PEG- EPS next Q0.43 Inst Own108.70% Short Float14.96% Perf Quarter22.02%
Income-59.72M P/S3.44 EPS this Y85.08% Inst Trans-5.09% Short Ratio10.73 Perf Half Y14.01%
Sales383.64M P/B2.04 EPS next Y302.66% ROA-4.74% Short Interest9.28M Perf YTD21.04%
Book/sh10.31 P/C2.95 EPS next 5Y113.92% ROE-8.84% 52W Range15.70 - 22.00 Perf Year29.95%
Cash/sh7.12 P/FCF6.59 EPS past 3/5Y-49.84% -24.00% ROIC-6.60% 52W High-4.55% Perf 3Y45.63%
Dividend Est.- EV/EBITDA5.95 Sales past 3/5Y-2.80% 6.27% Gross Margin80.62% 52W Low33.76% Perf 5Y59.15%
Dividend TTM- EV/Sales3.45 EPS Y/Y TTM-133.73% Oper. Margin47.57% Volatility1.31% 1.29% Perf 10Y11.76%
Dividend Ex-DateSep 08, 2015 Quick Ratio2.30 Sales Y/Y TTM17.90% Profit Margin-15.57% RSI (14)61.27 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio2.48 EPS Q/Q-260.80% SMA201.75% Beta0.37 Target Price55.00
Payout0.00% Debt/Eq0.70 Sales Q/Q13.75% SMA508.99% Rel Volume1.41 Prev Close21.46
Employees127 LT Debt/Eq0.40 EarningsMay 07 AMC SMA20011.64% Avg Volume864.40K Price21.00
IPOOct 05, 2004 Option/ShortYes / Yes EPS/Sales Surpr.-351.87% 7.21% Trades Volume1,218,207 Change-2.14%
Date Action Analyst Rating Change Price Target Change
Mar-07-25Initiated Scotiabank Sector Outperform $55
Jun-18-24Initiated Cantor Fitzgerald Overweight
Jul-20-22Initiated Goldman Neutral $16
Nov-20-17Initiated Deutsche Bank Hold $13
Jun-12-25 07:00AM
Jun-10-25 06:00AM
Jun-03-25 07:00AM
May-20-25 06:00AM
May-08-25 08:54AM
05:52PM Loading…
May-07-25 05:52PM
04:05PM
Apr-11-25 12:30AM
Mar-21-25 06:35PM
Mar-14-25 06:17PM
Mar-12-25 05:08PM
Mar-05-25 07:00AM
Feb-26-25 04:35PM
04:04PM
Feb-06-25 07:00AM
07:25AM Loading…
Dec-17-24 07:25AM
Dec-16-24 07:00AM
01:15AM
Nov-26-24 07:00AM
Nov-21-24 11:14PM
Nov-12-24 04:05PM
Nov-06-24 05:23PM
04:05PM
Sep-04-24 07:00AM
Jul-31-24 10:54PM
05:51PM
04:05PM
Jul-09-24 01:30PM
Jun-27-24 08:00AM
Jun-18-24 09:51AM
07:00AM Loading…
Jun-03-24 07:00AM
May-31-24 07:30AM
May-20-24 04:06AM
May-10-24 02:04PM
May-08-24 10:57PM
05:09PM
04:05PM
07:00AM
Apr-24-24 07:00AM
Mar-04-24 04:01PM
Feb-29-24 04:56PM
04:37PM
04:05PM
Feb-14-24 02:44AM
Jan-10-24 06:16PM
Nov-18-23 07:03AM
Nov-03-23 06:00AM
Nov-01-23 05:32PM
04:15PM
04:05PM
Sep-19-23 08:30AM
Sep-18-23 08:00AM
Aug-25-23 04:52PM
Aug-02-23 05:18PM
04:05PM
Jul-23-23 09:22AM
Jul-11-23 08:53PM
08:00AM
Jul-06-23 11:33AM
Jun-26-23 01:27AM
Jun-21-23 08:00PM
Jun-07-23 08:30AM
Jun-06-23 04:05PM
May-24-23 01:49PM
May-23-23 06:42PM
May-11-23 06:45PM
07:42AM
May-09-23 07:45PM
04:32PM
Apr-28-23 05:30PM
Apr-26-23 08:00PM
Apr-18-23 11:22AM
Apr-17-23 04:31PM
09:40AM
09:00AM
Apr-10-23 08:38AM
Apr-05-23 10:05AM
09:53AM
Apr-03-23 12:09PM
Mar-13-23 06:24PM
Feb-28-23 04:10PM
Feb-14-23 04:33PM
Feb-13-23 05:09AM
Jan-23-23 11:07AM
Jan-10-23 04:05PM
Jan-03-23 06:15PM
Dec-28-22 06:15PM
11:07AM
Dec-22-22 06:00PM
Dec-16-22 06:00PM
Nov-30-22 04:30PM
Nov-28-22 09:40AM
Nov-18-22 08:48AM
Nov-17-22 07:11AM
Nov-11-22 09:40AM
05:29AM
Nov-09-22 06:35PM
04:05PM
Oct-31-22 09:40AM
Oct-20-22 10:02AM
Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DENNER ALEXANDER J10% OwnerMar 06 '25Sale17.521,196,74620,964,2375,658,705Mar 06 09:30 PM
DENNER ALEXANDER J10% OwnerMar 05 '25Sale17.63270,3744,766,1266,855,451Mar 06 09:30 PM
DENNER ALEXANDER J10% OwnerMar 04 '25Sale17.63151,1752,665,0797,125,825Mar 06 09:30 PM